Mucopolysaccharidosis I (MPS I) (Hurler Syndrome):グローバル臨床試験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) 31
Apr 20, 2012: Athersys Announces Publication Of Results Of Preclinical Study Of MultiStem In Cell Transplant 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Sanofi 32
Clinical Trial Overview of Sanofi 32
Medical Resources International Pte Ltd 33
Clinical Trial Overview of Medical Resources International Pte Ltd 33
Cytomedix, Inc. 34
Clinical Trial Overview of Cytomedix, Inc. 34
ArmaGen Technologies, Inc. 35
Clinical Trial Overview of ArmaGen Technologies, Inc. 35
Clinical Trial Overview of Top Institutes / Government 36
Masonic Cancer Center 36
Clinical Trial Overview of Masonic Cancer Center 36
University of Minnesota 37
Clinical Trial Overview of University of Minnesota 37
University of California, Los Angeles 38
Clinical Trial Overview of University of California, Los Angeles 38
New York Medical College 39
Clinical Trial Overview of New York Medical College 39
Tehran University of Medical Sciences 40
Clinical Trial Overview of Tehran University of Medical Sciences 40
Center for International Blood and Marrow Transplant Research 41
Clinical Trial Overview of Center for International Blood and Marrow Transplant Research 41
Erasmus MC 42
Clinical Trial Overview of Erasmus MC 42
The University of Chicago 43
Clinical Trial Overview of The University of Chicago 43
University of Louisville 44
Clinical Trial Overview of University of Louisville 44
Five Key Clinical Profiles 45
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74


【レポート販売概要】

■ タイトル:Mucopolysaccharidosis I (MPS I) (Hurler Syndrome):グローバル臨床試験動向(2014年上半期)
■ 英文:Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年5月21日
■ 調査会社:GlobalData
■ 商品コード:GDHC2145CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。